Accra

Accra is rapidly emerging as a premier life sciences hub in West Africa, distinguished by its robust pharmaceutical manufacturing capabilities and a burgeoning biotechnology sector.

As the gateway to the ECOWAS market, the city is best known for its WHO-compliant facilities, with industry leaders like Atlantic Lifesciences and Ernest Chemists driving regional self-sufficiency in vaccines, biologics and essential medicines.

Accra’s healthcare innovation landscape is fueled by a vibrant digital health startup scene, focusing on AI-driven diagnostics and medical device distribution to bridge the gap in clinical care.

The ecosystem is anchored by world-class academic research at the Noguchi Memorial Institute for Medical Research, which leads the continent in infectious disease studies and genomic data discovery.

International investors are increasingly attracted to Ghana’s regulatory stability and the government’s "2024-2030 Pharmaceutical Policy," which incentivizes local production and technology transfer.

Strategic partnerships between public hospitals like Korle Bu Teaching Hospital and global biopharma firms are expanding the scope of inclusive clinical trials across the region.

With its focus on health equity and preventative care, Accra is positioning itself as a central node for life sciences investment in Africa.

The city’s commitment to standardized manufacturing and R&D excellence ensures its role as a critical player in the global health supply chain.